Results
26,107 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 | Setia VishwasChief Financial Officer |  MPLTMapLight Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $131K 4,803 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $131K 4,803 sh |
| May 6, 2026 traded May 4, 2026 |
| 19 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $111K 3,908 sh | May 6, 2026 traded May 4, 2026 |
| 19 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $248K 9,030 sh | May 6, 2026 traded May 4, 2026 |
| 19 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $155K 5,460 sh | May 6, 2026 traded May 4, 2026 |
| 19 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $271K 9,645 sh | May 6, 2026 traded May 5, 2026 |
| 19 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $463K 15.9K sh | May 6, 2026 traded May 6, 2026 |
| 18 | Matsuda MasaruSee Remarks |  ARQTArcutis Biotherapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $172K 7,372 sh | May 6, 2026 traded May 4, 2026 |
| 17 | Doyle Jonathan JDirector, Hd of Financial Services Group |  PIPRPIPER SANDLER COMPANIESOpen-market sale | SELL | $24K 300 sh | May 6, 2026 traded May 5, 2026 |
| 17 |  April McClain DelaneyDDependent child |  NDAQNASDAQ, INC.Purchase | BUY | $1,001 – $15K | May 6, 2026 traded Apr 24, 2026 |
| 17 | Carr DouglasSVP Finance & Operations |  IPSCCentury Therapeutics, Inc.Open-market sale | SELL | $618 264 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $60K 2,068 sh | May 6, 2026 traded May 6, 2026 |
| 16 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $8,750 296 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 700 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 683 sh | May 6, 2026 traded May 4, 2026 |
| 16 | April McClain DelaneyDDependent child |  MORNMorningstar, Inc.Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 30, 2026 |
| 16 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $229K 8,152 sh | May 6, 2026 traded May 6, 2026 |
| 16 | April McClain DelaneyDDependent child |  TECHBIO-TECHNE CorpSale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 8, 2026 |
| 16 | April McClain DelaneyDDependent child |  FBINFortune Brands Innovations, Inc.Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 24, 2026 |
| 16 | April McClain DelaneyDDependent child |  VIKViking Holdings LtdPartial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 20, 2026 |
| 16 | April McClain DelaneyDDependent child | VIKViking Holdings Ltd Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 16, 2026 |
| 16 | Inrig JulaCHIEF MEDICAL OFFICER |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $101K 2,174 sh | May 6, 2026 traded May 5, 2026 |
| 16 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $102K 2,181 sh | May 6, 2026 traded May 5, 2026 |
| 16 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $9,223 312 sh | May 6, 2026 traded May 4, 2026 |
| 16 | April McClain DelaneyDDependent child |  BROBROWN & BROWN, INC.Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 17, 2026 |
| 16 | April McClain DelaneyDDependent child | MORNMorningstar, Inc. Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 17, 2026 |
| 16 | April McClain DelaneyDDependent child | MORNMorningstar, Inc. Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 16, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 787 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $238K 8,496 sh | May 6, 2026 traded May 6, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $9,607 325 sh | May 6, 2026 traded May 4, 2026 |
| 14 | Watanabe ToddDirector, See Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 3,172 sh | May 6, 2026 traded May 4, 2026 |
| 14 | Porter James RichardDirector, President and CEO |  NUVLNuvalent, Inc.Open-market sale · 10b5-1 plan | SELL | $1.77M 17.4K sh | May 6, 2026 traded May 4, 2026 |
| 13 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $14K 310 sh | May 6, 2026 traded May 6, 2026 |
| 13 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $14K 311 sh | May 6, 2026 traded May 6, 2026 |
| 13 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $28K 968 sh | May 6, 2026 traded May 5, 2026 |
| 13 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 931 sh | May 6, 2026 traded May 5, 2026 |
| 12 | Schlachet AmirDirector, CEO |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $299K 9,450 sh | May 6, 2026 traded May 5, 2026 |
| 11 | Vairavan LathaSVP Chief Financial Officer | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $32K 1,341 sh | May 6, 2026 traded May 4, 2026 |
| 11 | Holleran KevinDirector, President and CEO |  HAYWHayward Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $764K 52.4K sh | May 6, 2026 traded May 5, 2026 |
| 11 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 884 sh | May 6, 2026 traded May 4, 2026 |
| 9 | Ong Chin YinChief Org Capability Officer |  GRABGrab Holdings LtdOpen-market sale · 10b5-1 plan | SELL | $136K 38.0K sh | May 6, 2026 traded May 4, 2026 |